Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.

Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.